Oncology

Latest News

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com

Patient Navigation Is Nonnegotiable in Cancer Care

By Maggie L. Shaw

May 1st 2025

Experts at the Community Oncology Conference discuss innovative patient navigation programs, emphasizing technology's role and the importance of human connection in cancer care.

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg

Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

By AJMC Contributor

May 1st 2025

Doctor carrying documentation for patient care | image credit: Kanisorn - stock.adobe.com.jpeg

NCODA Outlines New Patient-Centered Oncology Distribution Models

By Pearl Steinzor

May 1st 2025

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

New Developments Warrant Rethinking HCC Transplant Criteria

By Jared Kaltwasser

April 29th 2025

Women with fatigue | Image credit: Adobe Stock

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

By Mary Caffrey

April 29th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

March 1st 2017

Addressing Patient Needs Around the Cost of Care

Surabhi Dangi-Garimella, PhD

A key takeaway from a panel discussion at the Patient Access Network Foundation’s second cost-sharing roundtable was the need for educating stakeholders.

March 1st 2017

Concerning Trends in Colorectal Cancer Incidence Among Younger Adults

Christina Mattina

The incidence of colorectal cancer continues to decline for older Americans, but researchers have noticed a significant uptick in prevalence among young adults.

Barry Russo on How Education Can Help Practices Achieve OCM Implementation

March 1st 2017

Barry Russo on How Education Can Help Practices Achieve OCM Implementation

The Oncology Care Model (OCM) can challenge providers who are overwhelmed by the wide scope of data involved, according to Barry Russo, CEO of The Center for Cancer & Blood Disorders. He explained the importance of educating staff, physicians, and patients to help ease the journey towards any new model.

March 1st 2017

Kite Pharma Reports Positive Data From ZUMA-1, Evaluating a CAR-T Treatment

Median overall survival was not yet reached at a median follow-up of 8.7 months on the company’s ZUMA-1 trial.

February 28th 2017

Smilow's In-House Pharmacy Saved Costs, Beneficial to Patients

Surabhi Dangi-Garimella, PhD

Expanding a health system pharmacy’s operations to include specialty drugs, namely oral oncology agents, improved patient care by reducing errors and saving costs.

February 27th 2017

NCI-Funded Study Hopes to Unveil Disparity Among African American Cancer Survivors

Surabhi Dangi-Garimella, PhD

A new grant aims to gather data on thousands of African American cancer survivors to understand factors that influence disease progression, recurrence, mortality, and quality of life.

February 27th 2017

Proposed Colorectal Cancer Screening Initiatives Vary in Cost-Effectiveness

Christina Mattina

A recent cost-effectiveness analysis of 4 colorectal cancer screening initiatives found that some strategies may be more valuable than others in reducing screening disparities.

Jonathan Hirsch: Precision Medicine Is the Future of Value-Based Cancer Care

February 26th 2017

Jonathan Hirsch: Precision Medicine Is the Future of Value-Based Cancer Care

Precision medicine has demonstrated clinical utility and cost-effectiveness, which is why many believe this approach will be key to value-based cancer care in the future, said Jonathan Hirsch, founder and president of Syapse.

February 24th 2017

Personalizing Cancer Treatment Based on Muscle Mass to Reduce Toxicity

Surabhi Dangi-Garimella, PhD

Using body composition metrics to guide the dose in patients receiving anthracyclines-taxane—based chemotherapy for breast cancer can reduce treatment-related toxicity.

Podcast: Takeaways From the 5th Annual Patient-Centered Oncology Care Meeting

February 23rd 2017

Podcast: Takeaways From the 5th Annual Patient-Centered Oncology Care Meeting

Presenters and panelists at the 5th annual Patient-Centered Oncology Care meeting provide their key takeaways.

February 23rd 2017

Lenalidomide Approved as Maintenance for Multiple Myeloma Following Transplant

The FDA has approved lenalidomide as maintenance therapy in patients with multiple myeloma following autologous stem cell transplant.

Dr Joseph Alvarnas Discusses Awareness of Cancer Patients' Financial Concerns

February 23rd 2017

Dr Joseph Alvarnas Discusses Awareness of Cancer Patients' Financial Concerns

Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.

February 23rd 2017

AJMC®'s Evidence-Based Oncologyâ„¢ Publishes Third Annual Immuno-Oncology Issue

The advance of CAR-T technology and the rise of immuno-oncology alongside emerging new payment models highlight the annual review in Evidence-Based Oncologyâ„¢, which looks at how researchers are harnessing the immune system to bring unprecedented results in cancer care.

February 22nd 2017

Bundled Payments and Other Cost-Management Approaches to Oncology Care

Christina Mattina

At the 5th annual Patient-Centered Oncology CareÂ® meeting, stakeholders shared their views on how bundled payments, clinical pathways, and other value-based approaches can be implemented in cancer care while ensuring adequate care quality.

February 22nd 2017

Panel Presents Unique Cost-Sharing Viewpoints in Oncology Care

Christina Mattina

Panelists from diverse vantage points in the cancer care landscape discussed the effects of cost sharing on patients in a discussion at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 22nd 2017

Integrating Patient-Centered Outcomes in APMs

Surabhi Dangi-Garimella, PhD

As payment models shift to emphasize patient experience and quality of care, a panel discussion at the 5th annual Patient-Centered Oncology CareÂ® meeting debated whether these efforts had meaningfully improved outcomes for patients.

February 22nd 2017

CVS Decision to Stop Tobacco Sales Reduced Cigarette Purchase

Surabhi Dangi-Garimella, PhD

The company's study has found a 38% drop in cigarette purchase among shoppers who visit CVS stores.

February 22nd 2017

Exercise Most Powerful Lifestyle Factor in Improving Breast Cancer Outcomes

Christina Mattina

A recent literature review, examining evidence on lifestyle changes that can reduce the risk of recurrence or death for women diagnosed with breast cancer, found that exercise can reduce the risk of both outcomes.

Samantha Watson Describes How Cancer Patients Balance Health With Finances

February 22nd 2017

Samantha Watson Describes How Cancer Patients Balance Health With Finances

As founder and CEO of The Samfund, Samantha Watson has found that most cancer patients prioritize their physical health over their financial stability, leaving them lagging behind their peers economically or even facing bankruptcy.

February 21st 2017

Age, Plan Deductible Influence Prescription Changes Among Cancer Survivors

Researchers at the American Cancer Society have found that nonelderly cancer survivors enrolled in high-deductible health plans are more likely to seek a change to a lower-cost prescription medication compared with those without a cancer history.

February 21st 2017

Specialty Pharmacies Transforming Cancer Care

Surabhi Dangi-Garimella, PhD

Specialty pharmacies can collaborate with clinical teams to harness the power of health information technology and improve cancer care, according to panelists at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 21st 2017

Cholesterol-Lowering Medications Complement Endocrine Therapy in Breast Cancer

Surabhi Dangi-Garimella, PhD

Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor—positive early-stage breast cancer.

February 20th 2017

TAPUR Trial Expands Who Can Join Clinical Trials, If Payers Fund Genomic Tests

Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 20th 2017

Developments in Immunotherapy at PCOC®: The Living Drugs

Surabhi Dangi-Garimella, PhD

David L. Porter, MD, kicked off the 5th annual Patient-Centered Oncology CareÂ® (PCOCÂ®) meeting in Baltimore on November 17, 2016, with an update on chimeric antigen receptor T-cell therapy.

February 20th 2017

Responding to Patient Needs Central to Providing Value in Cancer Care

Christina Mattina

At the 5th annual Patient-Centered Oncology CareÂ® meeting, Nell Wood Buhlman of Press Ganey explained that oncology providers must focus on patient needs and minimize suffering in order to truly provide value in cancer care.

February 20th 2017

Immunoâ€Oncology Versus Precision Medicine: Where Is Cancer Care Headed?

Surabhi Dangi-Garimella, PhD

At the 5th annual Patient-Centered Oncology CareÂ® meeting, hosted by The American Journal of Managed CareÂ®, experts discussed the contradiction presented by immuno-oncology agents in the world of precision medicine.

February 20th 2017

The Future of Oncology Care: 2017 and Beyond

Christina Mattina

Bruce A. Feinberg, DO, moderated a panel at the 5th annual Patient-Centered Oncology CareÂ® meeting that brought stakeholders together to share their cancer care predictions for the upcoming year.

February 20th 2017

Cancer Trial Participants Can Successfully Self-Report Adverse Events

Christina Mattina

Adverse events from cancer clinical trials are currently reported by trial investigators, but a recent feasibility study found that patients can successfully and accurately report their own symptoms if given the opportunity.

February 19th 2017

OlympiAD Trial Reports Success With Olaparib and Predictive Diagnostic Test

Surabhi Dangi-Garimella, PhD

The trial successfully improved progression-free survival and also tested a BRCA diagnostic test in patients with ovarian cancer.

Dr Carrie Stricker on How Carevive Integrates Patient-Reported Outcomes Into Care Planning

February 19th 2017

Dr Carrie Stricker on How Carevive Integrates Patient-Reported Outcomes Into Care Planning

Carevive recognizes the importance of including patient-reported outcomes into the care planning process, so they have developed surveys that will provide patients with the resources to address those concerns, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

...

79 80 81 82 83 84 85 86 87

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions